As I wrote: 'If we get liste on TSX in Canada, this will attract institutional investors'.
first 3 months of 2022 (Q4 and year financials) will give us medium term direction and uplisting in Toronto should help even more.
We have the products, the market and distribution partners. Management must rapidly figure out why revenues are not (last 3 Q's) progressing and how to correct the situation.